Tel Aviv, Israel – Pangea Biomed, the startup behind the world’s most advanced cancer response predictor, ENLIGHT, is announcing a strategic collaboration with the Sharett Institute of Oncology and Hadassah Cancer Research Institute (HCRI) at the Hadassah University Hospital Ein-Kerem and Ultima Genomics, the developer of a revolutionary architecture for high-throughput genomic sequencing. This partnership […]
Partnership extends access in Asia to Parse’s growing single cell portfolio SEATTLE — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced an agreement with Taipei-based Prisma Biotech to broaden Parse’s reach in Taiwan and across Asia-Pacific. “Biotech, pharma, and academic researchers across Asia are boosting demand for Parse’s Evercode single cell sequencing solutions […]
Expanded gene offerings include new vector options, transparent pricing and expedited turnaround times CORALVILLE, Iowa – To enable pharmaceutical researchers to move quickly into their high‑throughput screening experiments, global genomics solutions provider Integrated DNA Technologies (IDT) today released rapid genes, a new offering in its synthetic biology portfolio. Available from 125 base pairs (bp) to 2000 […]
WEST HILLS, Calif. — Thermo Fisher Scientific Inc., the world leader in serving science, today announced that its SeCore™ CDx HLA A Sequencing System has been granted 510(k) clearance by the United States Food and Drug Administration (FDA) for use as a companion diagnostic with TECELRA® (afamitresgene autoleucel), Adaptimmune’s newly approved T-cell receptor (TCR) therapy for the […]
Assay Automation Makes Cutting-Edge Research More Accessible to Labs INDIANAPOLIS – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, in partnership with Illumina, a leader in DNA sequencing and array-based technologies, offers a promising new approach to oncology research delivering faster results with fewer touchpoints. The Illumina TruSight™ Oncology 500 DNA/RNA assay […]
Sysmex Corporation (HQ: Kobe, Japan; President: Kaoru Asano) announces today that it has expanded its strategic Alliance Agreement with QIAGEN N.V. (HQ: Venlo, The Netherlands; CEO: Thierry Bernard) to deepen their collaboration in genetic testing, including research and development, production, clinical development, and sales-marketing. Sysmex and QIAGEN have built a successful partnership since the initial […]
This joint effort will harness PacBio’s state-of-the-art HiFi sequencing technology to offer profound insights into genetic diversity, disease mechanisms, and clinical diagnoses within Singapore’s multi-ethnic population SINGAPORE — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced that Precision Health Research, Singapore (PRECISE) has chosen the Revio HiFi sequencing system for […]
Delivers Illumina’s flagship oncology products on its most powerful sequencers to enable comprehensive genomic profiling at greater scale and at lower overall costs for customers SAN DIEGO — Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced it has expanded its oncology menu for NovaSeq™ X Series customers. The […]
Singapore’s National Precision Medicine (NPM) programme will sequence 10,000 genomes to improve understanding of genetic architecture and diversity in Singapore’s multi-ethnic Asia population through advanced, nanopore-based sequencing technology Oxford Nanopore Technologies (Oxford Nanopore) has announced a landmark project with Singapore’s National Precision Medicine (NPM) programme , led by Precision Health Research, Singapore (PRECISE), aimed at […]
Merck today announced the closing of the transaction to acquire Mirus Bio for approximately US$ 600 million. Advances Merck’s ambition to provide fully integrated and comprehensive solution for viral vector manufacturing Mirus Bio’s leading GMP transfection reagents complement Merck’s upstream bioprocessing portfolio Combined portfolio meets customer needs as demand for novel modalities grows Darmstadt, Germany […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
